Thermo Fisher Scientific (TMO) Stock Rises 0.11% on Friday, Up 1.5% in a Month
Technical analysis of TMO stock on November 13, 2026: price 700.22 USD, trend uptrend, RSI 53.8, support 673.82, resistance 721.63.

Thermo Fisher Scientific closed Friday, November 13, at $700.22, up 0.11% on the day, as its price held above both its 20-day and 50-day averages. The technical picture leans bullish, but the latest session’s below-average volume and negative MACD histogram show that upward momentum is not yet broadly confirmed.
Why TMO is in focus today
Selected automatically from 8 NYSE (US) stocks by a technical-signal score with daily weighted randomisation — not a recommendation.
Trend & Price Action
The shares are 0.79% higher over five days and 1.48% higher over one month. The 20-day average rose 1.25% over five days to $695.77, while the 50-day average stands at $670.62. With the price above both averages and the shorter average above the longer one, the structure supports an uptrend; no new moving-average cross formed in the latest session. The price sits at 55% of its 20-day range, between support at $673.82 and resistance at $721.63, leaving it in the middle portion rather than at an extreme.
The trend is intact, but the advance is measured.
The three-month range runs from $580.00 to $727.56. As shown in the chart, the price remains below that high and near the center of its shorter-term range, a setup that leaves resistance relevant if buyers try to extend the climb.

Oscillators & Momentum
RSI at 53.8 is neutral, consistent with a market that has a modest upward bias but is not showing an overbought reading. Stochastic is also neutral, with %K at 58.6 and %D at 67.0. These readings do not show strong downside pressure, but neither do they signal a forceful breakout.
MACD momentum is negative: its histogram is -0.724, with MACD at 10.607 below the 11.331 signal line. That divergence matters because the price trend is rising while the momentum measure has weakened. As shown in the chart, the oscillators point to a pause or loss of acceleration rather than a confirmed trend reversal.

Volatility & Volume
Bollinger Bands are at normal width, with a bandwidth of 8.0%; the 58% %B reading places the price above the band midpoint but below the upper band. This is consistent with a moderate upward position rather than a stretched move. ATR is $21.52, or 3.1% of the share price, indicating moderate recent price movement.
Volume was 1,837,300 shares, about 0.8 times the 20-day average of 2,245,545. That means the latest gain came on lighter-than-usual participation, tempering its confirmation. OBV is rising, however, suggesting that volume accumulation has generally supported the uptrend.
Fundamental Context
According to its SEC filing, Thermo Fisher reported quarterly revenue of $12.14 billion for the quarter ended September 26, 2026, up 9.1% from $11.12 billion a year earlier. Net income was $1.72 billion, compared with $1.62 billion a year earlier, and diluted earnings per share were $4.64. The filing provides a business backdrop, while the verdict below follows the supplied technical signals.
Technical Verdict: BUY
BUY is the JournalArta Research call, with a score of +76. The main supports are the price above its 50-day average, the 20-day average above the 50-day, and the rising OBV; RSI at 53.8 is also in the stated 50–70 zone. The counter-signal is the negative MACD histogram at -0.724, alongside below-average latest-session volume. The verdict is invalidated if price falls below $663.67.
- Entry range: $684.10–$700.22
- Exit targets: $755.04 (target 1) and $809.87 (target 2)
- Stop-loss protection: $663.67
In plain English, the technical setup favors further gains, but momentum has softened and needs confirmation.
Summary Data TMO
| Last price | 700.22 USD |
| Change 1 day / 5 days / 1 month | 0.11% / 0.79% / 1.48% |
| Trend / MA-cross | uptrend / none |
| SMA20 / SMA50 | 695.77 / 670.62 |
| RSI (14) / Stochastic %K | 53.8 / 58.6 |
| Bollinger %B / ATR | 58% / 21.52 |
| Support / Resistance 20 days | 673.82 / 721.63 |
| Data as of | 14 November 2026 04:00 WIB |
| JournalArta research verdict (score) | Buy (+76) |
| Entry zone | 684.10 – 700.22 |
| Target 1 / 2 | 755.04 / 809.87 |
| Stop loss | 663.67 |
| Reward/risk | 1.5 / 3.0 |
Today's full Buy and Sell list for US stocks →
Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.
Track TMO stock price daily: live levels, support/resistance and our full TMO analysis history.
Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →- 1I’m A Celebrity 2026 Line-Up: Rooney Leads 11 Stars Into Jungle

- 2Mavericks Surfers Race to California for Waves Near 50 Feet

- 3NYC Medical Examiner Has Not Determined Cause of Death of Beau Rose Jessup

- 4Mountaineer Finds Ice Age Cave Bear Graveyard in the Dolomites

- 5Rugby League World Cup Final 2026: Kick-Off Times and How to Watch Kangaroos v New Zealand

Lifestyle7 Signs Your Social Battery Is Running Low (and Why You Keep Cancelling Plans)
Lifestyle · Food & HealthThanksgiving Food Safety: How Long Leftovers Last and the Safe Turkey Temperature
Lifestyle7 Quiet Habits of Emotionally Intelligent People, According to Psychologists
LifestylePeople Who Don’t Like Celebrating Their Birthday Often Share These 7 Traits












